Prophylactic dapagliflozin attenuates pulmonary vascular remodelling, preserves right ventricular function, and maintains exercise capacity in a monocrotaline-induced pulmonary hypertension rat model
Pulmonary arterial hypertension (PAH) is a progressive disorder characterised by vascular remodelling, elevated pulmonary vascular resistance, and right ventricular (RV) failure. Preventive strategies for at-risk populations remain absent. SGLT2 inhibitors confer pleiotropic cardioprotective benefits, yet their p...